Literature DB >> 18300851

Global risk stratification in primary hypertension: the role of the kidney.

Giovanna Leoncini1, Elena Ratto, Francesca Viazzi, Novella Conti, Valeria Falqui, Angelica Parodi, Cinzia Tomolillo, Giacomo Deferrari, Roberto Pontremoli.   

Abstract

OBJECTIVE: Microalbuminuria and a reduction in creatinine clearance are well known, independent predictors of unfavourable cardiovascular prognosis. Our aim was to evaluate the impact of renal damage on global risk stratification in 459 non-diabetic, untreated hypertensive patients (64% men, mean age 47.3 years).
METHODS: Renal damage was defined as creatinine clearance < 60 ml/min per 1.73 m2 (Cockcroft-Gault formula) or the presence of microalbuminuria (albumin to creatinine ratio). Cardiac and vascular organ damage was assessed by ultrasound scan. We evaluated the impact of renal damage, left ventricular hypertrophy and carotid atherosclerosis on risk stratification as recommended by the 2007 European Society of Hypertension-European Society of Cardiology Guidelines.
RESULTS: The prevalence of renal damage, microalbuminuria and creatinine clearance < 60 ml/min per 1.73 m2 was 24, 12 and 13%, respectively. There was no correlation between albuminuria and estimated creatinine clearance, and only 0.9% of patients showed microalbuminuria and reduced creatinine clearance simultaneously. The presence of renal damage entailed a 3.3 times higher risk of having cardiovascular abnormalities. Based on routine work-up, 58% of our study patients were classified as high-very high risk. The simultaneous evaluation of albuminuria and creatinine clearance resulted in a significant change in risk stratification, since 68% of patients were classified in the high-very high risk class. The search for left ventricular hypertrophy or carotid atherosclerosis by ultrasonography did not improve risk stratification significantly as compared to the assessment of renal damage.
CONCLUSIONS: Our findings support the assessment of renal abnormalities as the first step when evaluating target organ damage for cardiovascular risk assessment in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300851     DOI: 10.1097/HJH.0b013e3282f35c79

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome.

Authors:  Federico Guerra; Lucia Mancinelli; Alessia Buglioni; Valentina Pierini; Alessandro Rappelli; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-12-01

Review 2.  Microalbuminuria in primary hypertension: a guide to optimal patient management?

Authors:  Francesca Viazzi; Francesca Cappadona; Roberto Pontremoli
Journal:  J Nephrol       Date:  2016-07-14       Impact factor: 3.902

Review 3.  Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study.

Authors:  Giovanna Leoncini; Francesca Viazzi; Enrico Agabiti Rosei; Ettore Ambrosioni; Francesco V Costa; Gastone Leonetti; Achille C Pessina; Bruno Trimarco; Massimo Volpe; Giacomo Deferrari; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

Review 4.  End organ damage in hypertension.

Authors:  Roland E Schmieder
Journal:  Dtsch Arztebl Int       Date:  2010-12-10       Impact factor: 5.594

Review 5.  Early chronic kidney disease: diagnosis, management and models of care.

Authors:  Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

6.  Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study.

Authors:  G Cerasola; G Mulè; E Nardi; P Cusimano; A Palermo; R Arsena; M Guarneri; C Geraci; S Cottone
Journal:  J Hum Hypertens       Date:  2010-01       Impact factor: 3.012

7.  Global cardiovascular risk assessment in the management of primary hypertension: the role of the kidney.

Authors:  Francesca Viazzi; Giovanna Leoncini; Roberto Pontremoli
Journal:  Int J Hypertens       Date:  2013-07-29       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.